Cardiooncology
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion Criteria 1) No restriction on gender, age =18 years old; 2) Confirmed as malignant tumor through pathology, cytology, radiology, or ultrasound examination; 3) Meets diagnostic criteria for impaired cardiac function (left ventricular ejection fraction is borderline or decreased, abnormal electrocardiogram, BNP/cardiac troponin is borderline or elevated), coronary artery disease, or arrhythmia.
Exclusion criteria
Exclusion criteria: Individuals with incomplete clinical data.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical Efficacy;TCM Syndrome Score;The frequency and duration of angina attacks; | — |
Secondary
| Measure | Time frame |
|---|---|
| Three markers for myocardial infarction (Troponin I (cTnI), Creatine kinase-MB (CK-MB), and Myoglobin (Myo));N-terminal pro-B-type natriuretic peptide (NT-proBNP);Cardiac Color Doppler Examination;24-hour ambulatory electrocardiogram (ECG) monitoring for paroxysmal ventricular tachycardia (PVT) and ventricular premature contractions (PVCs).; | — |
Countries
China
Contacts
Guang'anmen Hospital, China Academy of Chinese Medical Sciences